Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6207654 | 0.98 | MEN1 (0.61) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL8566606 | 0.85 | MEN1 (0.49) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL13619977 | 0.84 | ATM (0.59) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL26333757 | 0.84 | ATM (0.62) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL29907950 | 0.84 | GAA (0.64) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL2826584 | 0.84 | GAA (0.64) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL18089027 | 0.83 | MTNR1A (0.58) | KMT2ATSHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19751948 | 0.83 | ATM (0.65) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL30027909 | 0.81 | MEN1 (0.58) | MEN1KMT2ATSHRMAPTTAAR1 | |
| SCHEMBL468013 | 0.81 | MEN1 (0.58) | MEN1KMT2ATSHRMAPTTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116528857-A | MALT-1 modulators | 艾克斯赛安西娅人工智能有限公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2021104486-A1 | COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF | 武汉朗来科技发展有限公司 | 2021-06-03 | — | — | WO | disclosed |
| US-20180310562-A1 | FUNGICIDAL PYRAZOLE MIXTURES | FMC CORP (US) | 2018-11-01 | — | — | US | disclosed |
| US-10015966-B2 | Fungicidal pyrazole mixtures | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170260142-A1 | SOLID FORMS OF FUNGICIDAL PYRAZOLES | DU PONT (US) | 2017-09-14 | — | — | US | disclosed |
| US-9688639-B2 | Solid forms of fungicidal pyrazoles | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20160242416-A1 | FUNGICIDAL ISOXAZOLINE CARBINOLS | DU PONT (US) | 2016-08-25 | — | — | US | disclosed |
| US-20160075661-A1 | SOLID FORMS OF FUNGICIDAL PYRAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-03-17 | — | — | US | disclosed |
| WO-2015157005-A1 | SUBSTITUTED TOLYL FUNGICIDE MIXTURES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20150266850-A1 | SUBSTITUTED TOLYL FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-24 | — | — | US | disclosed |
| US-20120165309-A1 | HETERO RING DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2397479-A1 | HETERO RING DERIVATIVE | Astellas Pharma Inc. (JP) | 2011-12-21 | — | — | EP | disclosed |
| WO-2010092962-A1 | HETERO RING DERIVATIVE | アステラス製薬株式会社 (JP) | 2010-08-19 | — | — | WO | disclosed |
| US-20100113371-A9 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | RANBAXY LABORATORIES LIMITED INC. (IN) | 2010-05-06 | — | — | US | disclosed |
| US-20100113371-A9 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | RANBAXY LABORATORIES LIMITED INC. (IN) | 2010-05-06 | — | — | US | disclosed |
| US-20090075909-A1 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | RANBAXY LABORATORIES LIMITED INC. (IN) | 2009-03-19 | — | — | US | disclosed |
| US-20090075909-A1 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | RANBAXY LABORATORIES LIMITED INC. (IN) | 2009-03-19 | — | — | US | disclosed |
| EP-0636625-B1 | Tricyclic diazepines vasopressin and oxytocin antagonists | AMERICAN CYANAMID CO (US) | 1999-01-27 | — | — | EP | disclosed |
| EP-0772601-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996003387-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090075909-A1 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | HLA-DRB1, IL5, TNF | MEN1 3635/4885KMT2A 4338/4885TSHR 3110/4885 |
| US-20150266850-A1 | SUBSTITUTED TOLYL FUNGICIDES | TH, CYP1B1, CYP1A1 | MEN1 1793/4885KMT2A 3392/4885TSHR 1379/4885 |
| US-20120165309-A1 | HETERO RING DERIVATIVE | IL2, PIK3R2, IL2RA | MEN1 4630/4885KMT2A 1656/4885TSHR 1779/4885 |
| US-20170260142-A1 | SOLID FORMS OF FUNGICIDAL PYRAZOLES | NOD1, AFF1, MAST1 | MEN1 1990/4885KMT2A 3857/4885TSHR 4163/4885 |
| US-10015966-B2 | Fungicidal pyrazole mixtures | CYP1B1, CBR3, CBR1 | MEN1 1666/4885KMT2A 4555/4885TSHR 2226/4885 |
| US-20160242416-A1 | FUNGICIDAL ISOXAZOLINE CARBINOLS | CYP1B1, CHRM1, CYP1A1 | MEN1 2476/4885KMT2A 1675/4885TSHR 3040/4885 |
| US-20160075661-A1 | SOLID FORMS OF FUNGICIDAL PYRAZOLES | NOD1, AFF1, MAST1 | MEN1 1990/4885KMT2A 3857/4885TSHR 4163/4885 |
| US-20180310562-A1 | FUNGICIDAL PYRAZOLE MIXTURES | CYP1B1, CBR3, CBR1 | MEN1 1666/4885KMT2A 4555/4885TSHR 2226/4885 |
| US-20100113371-A9 | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds | HLA-DRB1, IL5, TNF | MEN1 3635/4885KMT2A 4338/4885TSHR 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.